KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Gross Profit Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 54.44%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 9.77%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 15.45%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -0.16%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 13.38%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 7.57%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -65.16%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -1.22%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.38%
Dec 31, 2025 194.86%
Sep 30, 2025 -23.21%
Jun 30, 2025 76.67%
Mar 31, 2025 -29.43%
Dec 31, 2024 17.51%
Sep 30, 2024 65.43%
Jun 30, 2024 -0.41%
Mar 31, 2024 67.43%
Dec 31, 2023 494.72%
Sep 30, 2023 0.65%
Jun 30, 2023 1.75%
Mar 31, 2023 -6.24%
Dec 31, 2022 -111.31%
Sep 30, 2022 -0.65%
Jun 30, 2022 3.99%
Mar 31, 2022 6.03%
Dec 31, 2021 140.41%
Sep 30, 2021 -20.63%
Jun 30, 2021 3.62%
Mar 31, 2021 -5.10%
Dec 31, 2020 2.36%
Sep 30, 2020 45.06%
Jun 30, 2020 3.42%
Mar 31, 2020 -12.02%
Dec 31, 2019 -22.74%
Sep 30, 2019 -14.62%
Jun 30, 2019 -19.40%
Mar 31, 2019 -1.07%
Dec 31, 2018 8.10%
Sep 30, 2018 0.56%
Jun 30, 2018 1.65%
Mar 31, 2018 27.05%
Dec 31, 2017 -1.95%
Sep 30, 2017 14.86%
Jun 30, 2017 25.86%
Mar 31, 2017 -0.43%
Dec 31, 2016 -33.01%
Sep 30, 2016 0.16%
Jun 30, 2016 6.96%
Mar 31, 2016 9.89%
Dec 31, 2015 111.38%
Sep 30, 2015 18.57%
Jun 30, 2015 6.93%
Mar 31, 2015 -11.48%
Dec 31, 2014 -42.33%
Sep 30, 2014 -2.05%
Jun 30, 2014 1.52%
Mar 31, 2014 4.93%
Dec 31, 2013 419.13%
Sep 30, 2013 12.64%
Jun 30, 2013 10.50%
Mar 31, 2013 31.23%
Dec 31, 2012 -55.12%
Sep 30, 2012 13.33%
Jun 30, 2012 4.77%
Mar 31, 2012 3.18%
Dec 31, 2011 -43.87%
Sep 30, 2011 -4.70%
Jun 30, 2011 -8.91%
Mar 31, 2011 -13.41%
Dec 31, 2010 1.19%
Sep 30, 2010 -0.60%
Jun 30, 2010 0.78%
Mar 31, 2010 27.74%